Wellspring Financial Advisors LLC Has $655,000 Holdings in UnitedHealth Group Incorporated (NYSE:UNH)

Wellspring Financial Advisors LLC lessened its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 8.7% during the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 1,295 shares of the healthcare conglomerate’s stock after selling 124 shares during the period. Wellspring Financial Advisors LLC’s holdings in UnitedHealth Group were worth $655,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. M&T Bank Corp boosted its holdings in UnitedHealth Group by 13.4% in the third quarter. M&T Bank Corp now owns 220,590 shares of the healthcare conglomerate’s stock worth $128,975,000 after acquiring an additional 26,074 shares in the last quarter. Sugarloaf Wealth Management LLC grew its position in UnitedHealth Group by 17.6% in the 4th quarter. Sugarloaf Wealth Management LLC now owns 7,957 shares of the healthcare conglomerate’s stock valued at $4,025,000 after purchasing an additional 1,193 shares during the period. Signal Advisors Wealth LLC raised its holdings in UnitedHealth Group by 13.0% during the fourth quarter. Signal Advisors Wealth LLC now owns 9,115 shares of the healthcare conglomerate’s stock worth $4,611,000 after buying an additional 1,051 shares during the last quarter. Waycross Partners LLC grew its holdings in shares of UnitedHealth Group by 2.4% during the fourth quarter. Waycross Partners LLC now owns 27,794 shares of the healthcare conglomerate’s stock valued at $14,060,000 after buying an additional 658 shares during the last quarter. Finally, Discipline Wealth Solutions LLC bought a new position in UnitedHealth Group in the 3rd quarter valued at about $558,000. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

A number of research analysts have recently weighed in on UNH shares. Wells Fargo & Company dropped their target price on UnitedHealth Group from $694.00 to $660.00 and set an “overweight” rating on the stock in a report on Tuesday, January 28th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $700.00 target price on shares of UnitedHealth Group in a report on Friday, January 17th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research note on Thursday, January 23rd. Piper Sandler reduced their target price on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating for the company in a report on Thursday, January 2nd. Finally, Hsbc Global Res raised UnitedHealth Group from a “hold” rating to a “strong-buy” rating in a research report on Friday, January 10th. Twenty research analysts have rated the stock with a buy rating and two have issued a strong buy rating to the company. According to MarketBeat, the stock has an average rating of “Buy” and an average price target of $629.32.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of UnitedHealth Group stock in a transaction on Friday, January 17th. The shares were acquired at an average cost of $511.57 per share, for a total transaction of $511,570.00. Following the completion of the transaction, the director now directly owns 4,500 shares of the company’s stock, valued at approximately $2,302,065. The trade was a 28.57 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is available through this hyperlink. 0.33% of the stock is currently owned by insiders.

UnitedHealth Group Price Performance

Shares of NYSE:UNH opened at $524.94 on Monday. UnitedHealth Group Incorporated has a 12 month low of $436.38 and a 12 month high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The stock has a market cap of $480.17 billion, a P/E ratio of 33.87, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a 50 day moving average of $509.24 and a 200 day moving average of $541.85.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The company had revenue of $100.81 billion for the quarter, compared to the consensus estimate of $101.60 billion. During the same quarter last year, the business posted $5.83 earnings per share. The firm’s revenue was up 6.8% compared to the same quarter last year. As a group, sell-side analysts forecast that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Dividend Announcement

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th were issued a $2.10 dividend. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.60%. The ex-dividend date of this dividend was Monday, March 10th. UnitedHealth Group’s payout ratio is 54.19%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.